Lineage Cell Therapeutics, Inc. (LCTX)

1.70 -0.05 (-2.86%) USD  |  NYAM  |  Dec 19, 14:52
More

Lineage Cell Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for LCTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Ocugen, Inc. Upgrade
Belite Bio, Inc. Upgrade
CEL-SCI Corp. Upgrade
AIM ImmunoTech, Inc. Upgrade
IGC Pharma, Inc. Upgrade